Literature DB >> 29320807

Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality.

Bryan T Kelly1, Teng Moua2.   

Abstract

BACKGROUND AND
OBJECTIVE: Criteria for interstitial pneumonia with autoimmune features (IPAF) were recently established for research purposes in a joint statement from the European Respiratory Society (ERS) and American Thoracic Society (ATS). We reviewed the utility of these criteria in patients previously diagnosed as broadly defined undifferentiated connective tissue disease (UCTD) and noted overlapping IPAF findings. Additional review was given to IPAF patients with usual interstitial pneumonia (UIP) on histopathology or radiology in terms of survival and outcome.
METHODS: Patients with prior UCTD-interstitial lung disease (ILD) were screened by ERS/ATS criteria for IPAF. Clinical data along with all-cause mortality were collated and compared with selected idiopathic pulmonary fibrosis (IPF) patients from the same study period. Survival was compared between IPAF subgroups with and without UIP features.
RESULTS: One hundred and one UCTD-ILD subjects (91%) evaluated from 2005 to 2012 also met strict criteria for IPAF. Frequent clinical findings included Raynaud's phenomenon, positive anti-nuclear antibody (ANA) and non-specific interstitial pneumonia (NSIP) pattern on chest computed tomography (CT). Nineteen had features of UIP either on histopathology or CT imaging. As compared with IPF, IPAF patients had overall better survival except in those with UIP features.
CONCLUSION: Current IPAF criteria encompassed the majority of broadly defined UCTD-ILD and included those with UIP findings. Survival compared with IPF in those with UIP was similar. Further studies are necessary to refine IPAF definitions for clinical use and guide directed management strategies.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  autoimmune disease; idiopathic pulmonary fibrosis; interstitial lung disease; interstitial pneumonia; usual interstitial pneumonia

Mesh:

Year:  2018        PMID: 29320807     DOI: 10.1111/resp.13254

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  13 in total

Review 1.  Interstitial Pneumonia with Autoimmune Features.

Authors:  Bridget A Graney; Aryeh Fischer
Journal:  Ann Am Thorac Soc       Date:  2019-05

Review 2.  Interstitial Pneumonia With Autoimmune Features (IPAF).

Authors:  Ligia Fernandes; Mouhamad Nasser; Kais Ahmad; Vincent Cottin
Journal:  Front Med (Lausanne)       Date:  2019-09-27

3.  Krebs von den Lungen-6 and surfactant protein-A in interstitial pneumonia with autoimmune features.

Authors:  Mingshan Xue; Chuanxu Cai; Yifeng Zeng; Yifan Xu; Huai Chen; Haisheng Hu; Luqian Zhou; Baoqing Sun
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 4.  Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential.

Authors:  Marco Sebastiani; Paola Faverio; Andreina Manfredi; Giulia Cassone; Caterina Vacchi; Anna Stainer; Maria Rosa Pozzi; Carlo Salvarani; Alberto Pesci; Fabrizio Luppi
Journal:  Biomedicines       Date:  2020-12-26

5.  Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Adelle S Jee; Robert Sheehy; Peter Hopkins; Tamera J Corte; Christopher Grainge; Lauren K Troy; Karen Symons; Lissa M Spencer; Paul N Reynolds; Sally Chapman; Sally de Boer; Taryn Reddy; Anne E Holland; Daniel C Chambers; Ian N Glaspole; Helen E Jo; Jane F Bleasel; Jeremy P Wrobel; Leona Dowman; Matthew J S Parker; Margaret L Wilsher; Nicole S L Goh; Yuben Moodley; Gregory J Keir
Journal:  Respirology       Date:  2020-11-24       Impact factor: 6.424

Review 6.  Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features-What Do We Already Know?

Authors:  Ewa Miądlikowska; Patrycja Rzepka-Wrona; Joanna Miłkowska-Dymanowska; Adam Jerzy Białas; Wojciech Jerzy Piotrowski
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

7.  Variables Associated With Response to Therapy in Patients With Interstitial Pneumonia With Autoimmune Features.

Authors:  Elena K Joerns; Traci N Adams; Chad A Newton; Bonnie Bermas; David Karp; Kiran Batra; Jose Torrealba; Lesley Davila; Joan Reisch; Craig Glazer; Una E Makris
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902

Review 8.  Recent advances in the diagnosis and management of interstitial pneumonia with autoimmune features: the perspective of rheumatologists.

Authors:  Hong Ki Min; Se-Hee Kim; Sang-Heon Lee; Hae-Rim Kim
Journal:  Korean J Intern Med       Date:  2021-02-08       Impact factor: 2.884

9.  Outcomes of Idiopathic Pulmonary Fibrosis Improve with Obesity: A Rural Appalachian Experience.

Authors:  Rahul G Sangani; Andrew J Ghio; Hasan Mujahid; Zalak Patel; Kristen Catherman; Sijin Wen; John E Parker
Journal:  South Med J       Date:  2021-07       Impact factor: 0.810

10.  Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2019-12-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.